Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2009

View Archived Issues

Novel beta-secretase 1 inhibitors developed by Schering-Plough for AD therapy

Potent dual orexin receptor antagonist SB-649868 shows hypnotic properties in multiple studies

Novartis reports trial results of adjuvanted cell culture-based influenza A(H1N1) vaccine

Autologous immunosuppressive regulatory B cells show promise in autoimmune disease therapy in vivo

DTriP-22 shows potent anti-enterovirus 71 activity by inhibiting NS5B

Andrographolide analogue exhibits significant antibacterial activity

FDA Advisory Committee recommends approval of romidepsin for cutaneous T-cell lymphoma

Takeda presents results from first quarter of 2009, ending June 30

OSI initiates two clinical trials of OSI-906

GSK claims AMPA glutamate receptor ligands for psychotic disorders

FDA grants Cytopia clearance for CYT-387 trials in U.S.

Enanta identifies novel hepatitis C virus NS3 NS4A protease inhibitors

Phase II study suggests telmisartan may reverse epirubicin cardiotoxicity in cancer patients

Sanwa describes thyroid hormone receptor ligands for the treatment of hyperlipidemia

Taiho presents retinoid RARalpha receptor agonists as antitumor agents

Grifols launches anti-hepatitis B immunoglobulin, Niuliva

Endo launches Valstar for bladder cancer

Takeda receives FDA complete response letter for fixed-dose Actos and alogliptin benzoate

FDA accepts for review Bristol-Myers Squibb's BLA for belatacept

FDA issues warning for Myfortic

Array BioPharma reports topline results from phase II ARRY-162 trial

Dilafor reports phase II tafoxiparin results in preventing protracted labor

Acura and King Pharmaceuticals provide update on Acurox NDA

Shionogi reports results from first quarter 2009, ended June 30

Japanese launch for GSK's dutasteride for benign prostatic hyperplasia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...